Norihiko Takahashi - Concepedia

Author

Norihiko Takahashi

Also Known As

K. Kuwano, N TAKAHASHI, N Takahashi, N. Takahashi, N., Takahashi, NORIHIKO TAKAHASHI, Norihiko TAKAHASHI, Norihiko Takahashi, Takahashi Norihiko

163

Publications

2.2K

Citations

H-Index

106

Concepts

All Affiliations

Hokkaido University The University of Tokyo Hokkaido University Hospital Fujitsu (Japan)Keio University

About

Norihiko Takahashi is an author at Hokkaido University specializing in medicine, tumor biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	845
2	Cell Biology	7	7	654
3	Engineering	6	6	90
4	Natural Sciences	4	4	150
5	Applied Physics	4	4	54

Norihiko Takahashi

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Involvement of Macrophage Migration Inhibitory Factor (MIF) in the Mechanism of Tumor Cell Growth Norihiko Takahashi, Jun Nishihira, Yuji Sato, Molecular Medicine Tumor Cell GrowthImmunologyBiological MicroenvironmentsCell MigrationCell Proliferation	1998	159
Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide. Norihiko Takahashi, Akinao Haba, Fumihiko Matsuno, PubMed Clinical ImmunologyImmunologyDermatologyImmunotherapyTumor Biology	2001	152
AN ANTIBODY FOR MACROPHAGE MIGRATION INHIBITORY FACTOR SUPPRESSES TUMOUR GROWTH AND INHIBITS TUMOUR-ASSOCIATED ANGIOGENESIS Hideaki Ogawa, Jun Nishihira, Yuji Sato, Cytokine AngiogenesisMedicineImmunologyVascular BiologyNeovascularization	2000	131
IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4+ T cells Yosuke Ohno, Hidemitsu Kitamura, Norihiko Takahashi, Cancer Immunology Immunotherapy InflammationHuman Dendritic CellsAutoimmune DiseaseT-regulatory CellImmunology	2016	110
IL6 Modulates the Immune Status of the Tumor Microenvironment to Facilitate Metastatic Colonization of Colorectal Cancer Cells Yujiro Toyoshima, Hidemitsu Kitamura, Huihui Xiang, Cancer Immunology Research	2019	92
Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer–Initiating Cells and Is a Potent Target of Immunotherapy Rena Morita, Yoshihiko Hirohashi, Toshihiko Torigoe, Clinical Cancer Research	2016	85
Lack of interleukin‐6 in the tumor microenvironment augments type‐1 immunity and increases the efficacy of cancer immunotherapy Yosuke Ohno, Yujiro Toyoshima, Hideaki Yurino, Cancer Science	2017	82
Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer Takahiro Einama, Shigenori Homma, Hirofumi Kamachi, British Journal of Cancer	2012	77
CXCL12–CXCR7 axis is important for tumor endothelial cell angiogenic property Kenji Yamada, Nako Maishi, Kosuke Akiyama, International Journal of Cancer	2015	73
First clinical trial of cancer vaccine therapy with artificially synthesized helper/ killer‐hybrid epitope long peptide of MAGE‐A4 cancer antigen Norihiko Takahashi, Takayuki Ohkuri, Shigenori Homma, Cancer Science	2012	60

Page 1